NovaBridge Biosciences
NBP
$1.70
-$0.08-4.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -117.55M | -98.62M | -- | -- | -- |
| Total Depreciation and Amortization | 1.03M | 733.00K | -- | -- | -- |
| Total Amortization of Deferred Charges | 3.80M | 1.90M | -- | -- | -- |
| Total Other Non-Cash Items | 55.55M | 52.39M | -- | -- | -- |
| Change in Net Operating Assets | 11.49M | 14.38M | -- | -- | -- |
| Cash from Operations | -45.68M | -29.22M | -- | -- | -- |
| Capital Expenditure | -990.00K | -495.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.23M | 6.62M | -- | -- | -- |
| Cash from Investing | 12.24M | 6.12M | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 62.66M | 62.29M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.19M | -4.19M | -- | -- | -- |
| Cash from Financing | 58.47M | 58.10M | -- | -- | -- |
| Foreign Exchange rate Adjustments | 206.00K | 233.00K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 25.23M | 35.23M | -- | -- | -- |